Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide ...
A research team has developed a versatile machine learning model that could one day greatly expand what medical scans can ...
VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced the appointment of Dr. Arumugham ...
Background Metabolic dysfunction associated steatotic liver disease (MASLD), the most common chronic liver disease globally, may originate early in life. While maternal obesity is linked to offspring ...
ENDRA Life Sciences has reported results from a clinical study showing the Taeus Liver device’s high measurement consistency ...
A new blood test can help the early identification of liver scarring in liver disease. Learn more about this study.
Higher TSH levels and lower T3 levels may predict liver outcomes and % MACE risk among individuals with MASLD.
MASLD is present in over 70% of outpatients with type 2 diabetes. In addition, a 2-tier screening approach is useful for liver fibrosis stratification.
Advanced hepatic fibrosis is associated with a significantly higher risk for heart failure with preserved ejection fraction (HFpEF).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results